Innate lymphoid cells in allergic and nonallergic inflammation

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 5, 2016, Pages 1253-1264

  Morita, Hideaki ^a,b   Moro, Kazuyo ^c,d   Koyasu, Shigeo ^c,e  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Hochgebirgsklinik Children s Allergy and Asthma Hospital   (Switzerland)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

asthma; atopic dermatitis; eosinophilic gastrointestinal disorder; inflammatory bowel disease; Innate lymphoid cell; obesity; psoriasis; viral infection

Indexed keywords

ALLERGIC AIRWAY INFLAMMATION; ALLERGY; DERMATITIS; DIGESTIVE SYSTEM INFLAMMATION; HUMAN; INFLAMMATION; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SKIN ALLERGY; ANIMAL; GASTROINTESTINAL TRACT; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; LUNG; LYMPHOCYTE; SKIN;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; INFLAMMATION; LUNG; LYMPHOCYTES; SKIN;

EID: 84994891090     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.09.011     Document Type: Review

References (133)

1. 1 Cherrier, M., Sawa, S., Eberl, G., Notch, Id2, and RORgammat sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J Exp Med 209 (2012), 729–740.
2. 2 Constantinides, M.G., McDonald, B.D., Verhoef, P.A., Bendelac, A., A committed precursor to innate lymphoid cells. Nature 508 (2014), 397–401.
3. 3 Klose, C.S., Flach, M., Mohle, L., Rogell, L., Hoyler, T., Ebert, K., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157 (2014), 340–356.
4. 4 Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J.P., Eberl, G., et al. Innate lymphoid cells—a proposal for uniform nomenclature. Nat Rev Immunol 13 (2013), 145–149.
5. 5 Bernink, J.H., Peters, C.P., Munneke, M., te Velde, A.A., Meijer, S.L., Weijer, K., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14 (2013), 221–229.
6. 6 Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38 (2013), 769–781.
7. 7 Gordon, S.M., Chaix, J., Rupp, L.J., Wu, J., Madera, S., Sun, J.C., et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36 (2012), 55–67.
8. 8 Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463 (2010), 540–544.
9. 9 Mjosberg, J.M., Trifari, S., Crellin, N.K., Peters, C.P., van Drunen, C.M., Piet, B., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12 (2011), 1055–1062.
10. 10 Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464 (2010), 1367–1370.
11. 11 Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 107 (2010), 11489–11494.
12. 12 Mjosberg, J., Bernink, J., Golebski, K., Karrich, J.J., Peters, C.P., Blom, B., et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37 (2012), 649–659.
13. 13 Wilhelm, C., Hirota, K., Stieglitz, B., Van Snick, J., Tolaini, M., Lahl, K., et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12 (2011), 1071–1077.
14. 14 Turner, J.E., Morrison, P.J., Wilhelm, C., Wilson, M., Ahlfors, H., Renauld, J.C., et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 210 (2013), 2951–2965.
15. 15 Pelly, V.S., Kannan, Y., Coomes, S.M., Entwistle, L.J., Ruckerl, D., Seddon, B., et al. IL-4-producing ILC2s are required for the differentiation of T2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol, 2016 [Epub ahead of print].
16. 16 Yagi, R., Zhong, C., Northrup, D.L., Yu, F., Bouladoux, N., Spencer, S., et al. The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells. Immunity 40 (2014), 378–388.
17. 17 Serafini, N., Klein Wolterink, R.G., Satoh-Takayama, N., Xu, W., Vosshenrich, C.A., Hendriks, R.W., et al. Gata3 drives development of RORgammat+ group 3 innate lymphoid cells. J Exp Med 211 (2014), 199–208.
18. 18 Bal, S.M., Bernink, J.H., Nagasawa, M., Groot, J., Shikhagaie, M.M., Golebski, K., et al. IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol 17 (2016), 636–645.
19. 19 Ohne, Y., Silver, J.S., Thompson-Snipes, L., Collet, M.A., Blanck, J.P., Cantarel, B.L., et al. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat Immunol 17 (2016), 646–655.
20. 20 Xue, L., Salimi, M., Panse, I., Mjosberg, J.M., McKenzie, A.N., Spits, H., et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 133 (2014), 1184–1194.
21. 21 Doherty, T.A., Khorram, N., Lund, S., Mehta, A.K., Croft, M., Broide, D.H., Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol 132 (2013), 205–213.
22. 22 Monticelli, L.A., Sonnenberg, G.F., Abt, M.C., Alenghat, T., Ziegler, C.G., Doering, T.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12 (2011), 1045–1054.
23. 23 Mebius, R.E., Rennert, P., Weissman, I.L., Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7 (1997), 493–504.
24. 24 Adachi, S., Yoshida, H., Kataoka, H., Nishikawa, S., Three distinctive steps in Peyer's patch formation of murine embryo. Int Immunol 9 (1997), 507–514.
25. 25 Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009), 722–725.
26. 26 Satoh-Takayama, N., Lesjean-Pottier, S., Vieira, P., Sawa, S., Eberl, G., Vosshenrich, C.A., et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 207 (2010), 273–280.
27. 27 Sonnenberg, G.F., Monticelli, L.A., Elloso, M.M., Fouser, L.A., Artis, D., CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34 (2011), 122–134.
28. 28 Vonarbourg, C., Mortha, A., Bui, V.L., Hernandez, P.P., Kiss, E.A., Hoyler, T., et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33 (2010), 736–751.
29. 29 Crellin, N.K., Trifari, S., Kaplan, C.D., Satoh-Takayama, N., Di Santo, J.P., Spits, H., Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33 (2010), 752–764.
30. 30 Bernink, J.H., Krabbendam, L., Germar, K., de Jong, E., Gronke, K., Kofoed-Nielsen, M., et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43 (2015), 146–160.
31. 31 Mizuno, S., Mikami, Y., Kamada, N., Handa, T., Hayashi, A., Sato, T., et al. Cross-talk between RORgammat+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease. Inflamm Bowel Dis 20 (2014), 1426–1434.
32. 32 Lim, A.I., Menegatti, S., Bustamante, J., Le Bourhis, L., Allez, M., Rogge, L., et al. IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J Exp Med 213 (2016), 569–583.
33. 33 Silver, J.S., Kearley, J., Copenhaver, A.M., Sanden, C., Mori, M., Yu, L., et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17 (2016), 626–635.
34. 34 Grotenboer, N.S., Ketelaar, M.E., Koppelman, G.H., Nawijn, M.C., Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol 131 (2013), 856–865.
35. 35 Tamari, M., Tanaka, S., Hirota, T., Genome-wide association studies of allergic diseases. Allergol Int 62 (2013), 21–28.
36. 36 Oboki, K., Ohno, T., Kajiwara, N., Saito, H., Nakae, S., IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 59 (2010), 143–160.
37. 37 Bartemes, K.R., Kephart, G.M., Fox, S.J., Kita, H., Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 134 (2014), 671–678.e4.
38. 38 Liu, T., Wu, J., Zhao, J., Wang, J., Zhang, Y., Liu, L., et al. Type 2 innate lymphoid cells: a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma. Respir Med 109 (2015), 1391–1396.
39. 39 Smith, S.G., Chen, R., Kjarsgaard, M., Huang, C., Oliveria, J.P., O'Byrne, P.M., et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137 (2016), 75–86.e8.
40. 40 Christianson, C.A., Goplen, N.P., Zafar, I., Irvin, C., Good, J.T. Jr., Rollins, D.R., et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol 136 (2015), 59–68.e14.
41. 41 Nagakumar, P., Denney, L., Fleming, L., Bush, A., Lloyd, C.M., Saglani, S., Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol 137 (2016), 624–626.e6.
42. 42 Morita, H., Arae, K., Unno, H., Miyauchi, K., Toyama, S., Nambu, A., et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity 43 (2015), 175–186.
43. 43 Kabata, H., Moro, K., Fukunaga, K., Suzuki, Y., Miyata, J., Masaki, K., et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat Commun, 4, 2013, 2675.
44. 44 Halim, T.Y., Krauss, R.H., Sun, A.C., Takei, F., Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36 (2012), 451–463.
45. 45 Barlow, J.L., Bellosi, A., Hardman, C.S., Drynan, L.F., Wong, S.H., Cruickshank, J.P., et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 129 (2012), 191–198 e1-4.
46. 46 Klein Wolterink, R.G., Kleinjan, A., van Nimwegen, M., Bergen, I., de Bruijn, M., Levani, Y., et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 42 (2012), 1106–1116.
47. 47 Bartemes, K.R., Iijima, K., Kobayashi, T., Kephart, G.M., McKenzie, A.N., Kita, H., IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 188 (2012), 1503–1513.
48. 48 Doherty, T.A., Khorram, N., Chang, J.E., Kim, H.K., Rosenthal, P., Croft, M., et al. STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria. Am J Physiol Lung Cell Mol Physiol 303 (2012), L577–L588.
49. 49 Chang, Y.J., Kim, H.Y., Albacker, L.A., Baumgarth, N., McKenzie, A.N., Smith, D.E., et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12 (2011), 631–638.
50. 50 Takai, T., Ikeda, S., Barrier dysfunction caused by environmental proteases in the pathogenesis of allergic diseases. Allergol Int 60 (2011), 25–35.
51. 51 Milne, J., Brand, S., Occupational asthma after inhalation of dust of the proteolytic enzyme, papain. Br J Ind Med 32 (1975), 302–307.
52. 52 Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 107 (2010), 18581–18586.
53. 53 Motomura, Y., Morita, H., Moro, K., Nakae, S., Artis, D., Endo, T.A., et al. Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity 40 (2014), 758–771.
54. 54 Maazi, H., Patel, N., Sankaranarayanan, I., Suzuki, Y., Rigas, D., Soroosh, P., et al. ICOS: ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 42 (2015), 538–551.
55. 55 Morita, H., Saito, H., Matsumoto, K., Nakae, S., Regulatory roles of mast cells in immune responses. Semin Immunopathol 38 (2016), 623–629.
56. 56 Shaw, J.L., Fakhri, S., Citardi, M.J., Porter, P.C., Corry, D.B., Kheradmand, F., et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med 188 (2013), 432–439.
57. 57 Reese, T.A., Liang, H.E., Tager, A.M., Luster, A.D., Van Rooijen, N., Voehringer, D., et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447 (2007), 92–96.
58. 58 Van Dyken, S.J., Mohapatra, A., Nussbaum, J.C., Molofsky, A.B., Thornton, E.E., Ziegler, S.F., et al. Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and gammadelta T cells. Immunity 40 (2014), 414–424.
59. 59 Stier, M.T., Bloodworth, M.H., Toki, S., Newcomb, D.C., Goleniewska, K., Boyd, K.L., et al. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J Allergy Clin Immunol 138 (2016), 814–824.e11.
60. 60 Lee, H.C., Headley, M.B., Loo, Y.M., Berlin, A., Gale, M. Jr., Debley, J.S., et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol 130 (2012), 1187–1196.e5.
61. 61 Hong, J.Y., Bentley, J.K., Chung, Y., Lei, J., Steenrod, J.M., Chen, Q., et al. Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J Allergy Clin Immunol 134 (2014), 429–439.
62. 62 Jackson, D.J., Gangnon, R.E., Evans, M.D., Roberg, K.A., Anderson, E.L., Pappas, T.E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 178 (2008), 667–672.
63. 63 Gold, M.J., Antignano, F., Halim, T.Y., Hirota, J.A., Blanchet, M.R., Zaph, C., et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133 (2014), 1142–1148.
64. 64 Halim, T.Y., Steer, C.A., Matha, L., Gold, M.J., Martinez-Gonzalez, I., McNagny, K.M., et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40 (2014), 425–435.
65. 65 Drake, L.Y., Iijima, K., Kita, H., Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice. Allergy 69 (2014), 1300–1307.
66. 66 Mirchandani, A.S., Besnard, A.G., Yip, E., Scott, C., Bain, C.C., Cerovic, V., et al. Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J Immunol 192 (2014), 2442–2448.
67. 67 Halim, T.Y., Hwang, Y.Y., Scanlon, S.T., Zaghouani, H., Garbi, N., Fallon, P.G., et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol 17 (2016), 57–64.
68. 68 Barnig, C., Cernadas, M., Dutile, S., Liu, X., Perrella, M.A., Kazani, S., et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med, 5, 2013, 174ra26.
69. 69 Chang, J.E., Doherty, T.A., Baum, R., Broide, D., Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis. J Allergy Clin Immunol 133 (2014), 899–901.e3.
70. 70 Schleimer, R.P., Fox, C.C., Naclerio, R.M., Plaut, M., Creticos, P.S., Togias, A.G., et al. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol 76 (1985), 369–374.
71. 71 Harvima, I.T., Levi-Schaffer, F., Draber, P., Friedman, S., Polakovicova, I., Gibbs, B.F., et al. Molecular targets on mast cells and basophils for novel therapies. J Allergy Clin Immunol 134 (2014), 530–544.
72. 72 Allakhverdi, Z., Smith, D.E., Comeau, M.R., Delespesse, G., Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179 (2007), 2051–2054.
73. 73 Ho, L.H., Ohno, T., Oboki, K., Kajiwara, N., Suto, H., Iikura, M., et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 82 (2007), 1481–1490.
74. 74 Malo, J.L., Ghezzo, H., D'Aquino, C., L'Archeveque, J., Cartier, A., Chan-Yeung, M., Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol 90 (1992), 937–944.
75. 75 Moro, K., Kabata, H., Tanabe, M., Koga, S., Takeno, N., Mochizuki, M., et al. Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol 17 (2016), 76–86.
76. 76 Duerr, C.U., McCarthy, C.D., Mindt, B.C., Rubio, M., Meli, A.P., Pothlichet, J., et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat Immunol 17 (2016), 65–75.
77. 77 Molofsky, A.B., Van Gool, F., Liang, H.E., Van Dyken, S.J., Nussbaum, J.C., Lee, J., et al. Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 43 (2015), 161–174.
78. 78 McHedlidze, T., Kindermann, M., Neves, A.T., Voehringer, D., Neurath, M.F., Wirtz, S., IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells. Mucosal Immunol, 2016 [Epub ahead of print].
79. 79 Zhou, W., Toki, S., Zhang, J., Goleniewksa, K., Newcomb, D.C., Cephus, J.Y., et al. Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses. Am J Respir Crit Care Med 193 (2016), 31–42.
80. 80 Wenzel, S.E., Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18 (2012), 716–725.
81. 81 Julia, V., Macia, L., Dombrowicz, D., The impact of diet on asthma and allergic diseases. Nat Rev Immunol 15 (2015), 308–322.
82. 82 Kim, H.Y., Lee, H.J., Chang, Y.J., Pichavant, M., Shore, S.A., Fitzgerald, K.A., et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 20 (2014), 54–61.
83. 83 Everaere, L., Ait-Yahia, S., Molendi-Coste, O., Vorng, H., Quemener, S., LeVu, P., et al. Innate lymphoid cells contribute to allergic airway disease exacerbation by obesity. J Allergy Clin Immunol, 2016 [Epub ahead of print].
84. 84 Brestoff, J.R., Kim, B.S., Saenz, S.A., Stine, R.R., Monticelli, L.A., Sonnenberg, G.F., et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519 (2015), 242–246.
85. 85 Weidinger, S., Novak, N., Atopic dermatitis. Lancet 387 (2016), 1109–1122.
86. 86 Soumelis, V., Reche, P.A., Kanzler, H., Yuan, W., Edward, G., Homey, B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3 (2002), 673–680.
87. 87 Wang, Y.H., Angkasekwinai, P., Lu, N., Voo, K.S., Arima, K., Hanabuchi, S., et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 204 (2007), 1837–1847.
88. 88 Savinko, T., Matikainen, S., Saarialho-Kere, U., Lehto, M., Wang, G., Lehtimaki, S., et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 132 (2012), 1392–1400.
89. 89 Kim, B.S., Siracusa, M.C., Saenz, S.A., Noti, M., Monticelli, L.A., Sonnenberg, G.F., et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med, 5, 2013, 170ra16.
90. 90 Salimi, M., Barlow, J.L., Saunders, S.P., Xue, L., Gutowska-Owsiak, D., Wang, X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210 (2013), 2939–2950.
91. 91 Teunissen, M.B., Munneke, J.M., Bernink, J.H., Spuls, P.I., Res, P.C., Te Velde, A., et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 134 (2014), 2351–2360.
92. 92 Imai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A 110 (2013), 13921–13926.
93. 93 Li, M., Messaddeq, N., Teletin, M., Pasquali, J.L., Metzger, D., Chambon, P., Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci U S A 102 (2005), 14795–14800.
94. 94 Yoo, J., Omori, M., Gyarmati, D., Zhou, B., Aye, T., Brewer, A., et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202 (2005), 541–549.
95. 95 Kim, B.S., Wang, K., Siracusa, M.C., Saenz, S.A., Brestoff, J.R., Monticelli, L.A., et al. Basophils promote innate lymphoid cell responses in inflamed skin. J Immunol 193 (2014), 3717–3725.
96. 96 Otsuka, A., Nonomura, Y., Kabashima, K., Roles of basophils and mast cells in cutaneous inflammation. Semin Immunopathol 38 (2016), 563–570.
97. 97 Hoyler, T., Klose, C.S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E.L., et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37 (2012), 634–648.
98. 98 Tang, A., Amagai, M., Granger, L.G., Stanley, J.R., Udey, M.C., Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361 (1993), 82–85.
99. 99 Trautmann, A., Altznauer, F., Akdis, M., Simon, H.U., Disch, R., Brocker, E.B., et al. The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol 117 (2001), 927–934.
100. 100 Nestle, F.O., Kaplan, D.H., Barker, J., Psoriasis. N Engl J Med 361 (2009), 496–509.
101. 101 Bowcock, A.M., Krueger, J.G., Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5 (2005), 699–711.
102. 102 Villanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G.K., et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 134 (2014), 984–991.
103. 103 Dyring-Andersen, B., Geisler, C., Agerbeck, C., Lauritsen, J.P., Gudjonsdottir, S.D., Skov, L., et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 170 (2014), 609–616.
104. 104 Pantelyushin, S., Haak, S., Ingold, B., Kulig, P., Heppner, F.L., Navarini, A.A., et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122 (2012), 2252–2256.
105. 105 Li, Z., Hodgkinson, T., Gothard, E.J., Boroumand, S., Lamb, R., Cummins, I., et al. Epidermal Notch1 recruits RORgamma(+) group 3 innate lymphoid cells to orchestrate normal skin repair. Nat Commun, 7, 2016, 11394.
106. 106 Rothenberg, M.E., Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113 (2004), 11–29.
107. 107 Cianferoni, A., Spergel, J.M., Eosinophilic esophagitis and gastroenteritis. Curr Allergy Asthma Rep, 15, 2015, 58.
108. 108 Mishra, A., Hogan, S.P., Brandt, E.B., Rothenberg, M.E., IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 168 (2002), 2464–2469.
109. 109 Blanchard, C., Mingler, M.K., Vicario, M., Abonia, J.P., Wu, Y.Y., Lu, T.X., et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 120 (2007), 1292–1300.
110. 110 Rothenberg, M.E., Spergel, J.M., Sherrill, J.D., Annaiah, K., Martin, L.J., Cianferoni, A., et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 42 (2010), 289–291.
111. 111 Simon, D., Radonjic-Hosli, S., Straumann, A., Yousefi, S., Simon, H.U., Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation. Allergy 70 (2015), 443–452.
112. 112 Doherty, T.A., Baum, R., Newbury, R.O., Yang, T., Dohil, R., Aquino, M., et al. Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis. J Allergy Clin Immunol 136 (2015), 792–794.e3.
113. 113 Shoda, T., Matsuda, A., Arai, K., Shimizu, H., Morita, H., Orihara, K., et al. Sera of patients with infantile eosinophilic gastroenteritis showed a specific increase in both thymic stromal lymphopoietin and IL-33 levels. J Allergy Clin Immunol 138 (2016), 299–303.
114. 114 Neurath, M.F., Cytokines in inflammatory bowel disease. Nat Rev Immunol 14 (2014), 329–342.
115. 115 Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
116. 116 Fuss, I.J., Neurath, M., Boirivant, M., Klein, J.S., de la Motte, C., Strong, S.A., et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157 (1996), 1261–1270.
117. 117 Sakuraba, A., Sato, T., Kamada, N., Kitazume, M., Sugita, A., Hibi, T., Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 137 (2009), 1736–1745.
118. 118 Rovedatti, L., Kudo, T., Biancheri, P., Sarra, M., Knowles, C.H., Rampton, D.S., et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 58 (2009), 1629–1636.
119. 119 Takayama, T., Kamada, N., Chinen, H., Okamoto, S., Kitazume, M.T., Chang, J., et al. Imbalance of NKp44(+)NKp46(−) and NKp44(−)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 139 (2010), 882–892 e1-3.
120. 120 Cella, M., Otero, K., Colonna, M., Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci U S A 107 (2010), 10961–10966.
121. 121 Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 206 (2009), 1465–1472.
122. 122 Kim, C.J., Nazli, A., Rojas, O.L., Chege, D., Alidina, Z., Huibner, S., et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol 5 (2012), 670–680.
123. 123 Mizoguchi, A., Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis 18 (2012), 1777–1784.
124. 124 Bishop, J.L., Roberts, M.E., Beer, J.L., Huang, M., Chehal, M.K., Fan, X., et al. Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells. Mucosal Immunol 7 (2014), 405–416.
125. 125 Sawa, S., Lochner, M., Satoh-Takayama, N., Dulauroy, S., Berard, M., Kleinschek, M., et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 12 (2011), 320–326.
126. 126 Eken, A., Singh, A.K., Treuting, P.M., Oukka, M., IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol 7 (2014), 143–154.
127. 127 Geremia, A., Arancibia-Carcamo, C.V., Fleming, M.P., Rust, N., Singh, B., Mortensen, N.J., et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 208 (2011), 1127–1133.
128. 128 Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov II, Littman, D.R., Maloy, K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464 (2010), 1371–1375.
129. 129 Powell, N., Walker, A.W., Stolarczyk, E., Canavan, J.B., Gokmen, M.R., Marks, E., et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 37 (2012), 674–684.
130. 130 Hueber, W., Sands, B.E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P.D., et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61 (2012), 1693–1700.
131. 131 Mortha, A., Chudnovskiy, A., Hashimoto, D., Bogunovic, M., Spencer, S.P., Belkaid, Y., et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science, 343, 2014, 1249288.
132. 132 Hepworth, M.R., Monticelli, L.A., Fung, T.C., Ziegler, C.G., Grunberg, S., Sinha, R., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498 (2013), 113–117.
133. 133 Hepworth, M.R., Fung, T.C., Masur, S.H., Kelsen, J.R., McConnell, F.M., Dubrot, J., et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science 348 (2015), 1031–1035.